2020 full-year results and update on the progress of main programs
07/04/2021
Download PDF File (1443Ko)
THERANEXUS extends the capabilities of Neurolead, its active agent screening platform, to autophagy and neurological lysosomal storage disorders
09/03/2021
Download PDF File (326Ko)
Semi-annual liquidity contract summary - H2 2020
19/01/2021
Download PDF File (538Ko)
THERANEXUS presents an update on the progress of its main programs and announces its cash position as of 31 December 2020
18/01/2021
Download PDF File (538Ko)